Glox Therapeutics Limited is an active company incorporated on 27 February 2023 with the registered office located in Glasgow, City of Glasgow. Glox Therapeutics Limited was registered 2 years 8 months ago.
Termination of appointment of Niklas Czeloth as a director on 12 August 2025
Submitted on 6 Nov 2025
Termination of appointment of James Scott Clark as a director on 26 September 2025
Submitted on 6 Nov 2025
Appointment of Dr Paul Nicklin as a director on 12 August 2025
Submitted on 6 Nov 2025
Accounts for a small company made up to 31 December 2024
Submitted on 12 Sep 2025
Statement of capital following an allotment of shares on 25 March 2025
Submitted on 21 Jul 2025
Termination of appointment of Patricia Barbara Ann Barclay as a secretary on 14 May 2025
Submitted on 18 Jul 2025
Confirmation statement made on 26 February 2025 with no updates
Submitted on 26 Mar 2025
Appointment of Dr Michael Stephen Murray as a director on 6 February 2025
Submitted on 6 Feb 2025
Notification of a person with significant control statement
Submitted on 20 Nov 2024
Registered office address changed from , 11 the Square University of Glasgow, University Avenue, Glasgow, G12 8QQ, United Kingdom to John Arbuthnott Building Strathclyde University of Pharmacy & Biomedical 161 Cathedral Street Glasgow G4 0RE on 17 September 2024